Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-10
2006-10-10
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S221000, C540S556000
Reexamination Certificate
active
07119087
ABSTRACT:
Compound corresponding to the general formula (I)in which R2represents a chlorine atom, a methyl group or a 3-thienyl group.Therapeutic application.
REFERENCES:
patent: 4826848 (1989-05-01), Janssens et al.
patent: 6407095 (2002-06-01), Lochead et al.
patent: 6809094 (2004-10-01), O'Neill et al.
patent: 2003/0153574 (2003-08-01), Galli et al.
patent: 1219622 (2002-07-01), None
patent: WO 00/34279 (2000-06-01), None
Galli Frederic
Leclerc Odile
Lochead Alistair
Coleman Brenda
Gupta Balaram
Sanofi-Aventis
LandOfFree
4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642371